Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease and the Limitations of Patients' Activities in Primary Care.

NCT01219946 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01219946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01219946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease and the Limitations of Patients' Activities in Primary Care.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
March 31, 2011
Enrollment
700 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease